Pivotal Group has acquired Phoenix-based Precision Science, marking its first acquisition in the animal health industry
Founded in 1989, Precision Science provides contract manufacturing, product research and development for global animal health companies. Its product capabilities cover:
-
Veterinary pharmaceuticals
-
Medicated feed additives
-
Animal health supplements
-
Product development and analytical services

A major manufacturing expansion is already underway
The acquisition is accompanied by investment in a new, highly automated 130,000-square-foot facility in North Phoenix. At the time of the announcement, construction was approximately two-thirds complete. The new facility is expected to:
-
Add three manufacturing lines
-
Expand manufacturing into liquid formulations
-
Increase analytical testing capabilities
-
Strengthen product development infrastructure
-
Expand storage and logistics capacity
Pivotal says it has already invested capital and resources following the transaction’s closing.
Why this is important
This is more than a financial acquisition. It is a strategic investment in the animal health manufacturing supply chain. The industry is witnessing growing demand for differentiated formulations, specialised veterinary dosage forms, nutritional supplements and outsourced manufacturing.
A larger, integrated contract manufacturing platform can provide global animal health companies with additional production capacity without requiring them to build all their manufacturing infrastructure internally.
The development is also relevant to emerging animal health businesses in India, where CDMO capabilities can be an important competitive advantage.
What to watch next: Capacity commissioning, new customer contracts, regulatory inspections, additional manufacturing lines and the potential for further acquisitions in animal health manufacturing.

